Accéder au contenu
Merck

A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond.

Nature protocols (2008-06-13)
Sen Wu, Guoxin Ying, Qiang Wu, Mario R Capecchi
RÉSUMÉ

We describe here a streamlined procedure for targeting vector construction, which often is a limiting factor for gene targeting (knockout) technology. This procedure combines various highly efficient recombination-based cloning methods in bacteria, consisting of three steps. First step is the use of Red-pathway-mediated recombination (recombineering) to capture a genomic fragment into a Gateway-compatible vector. Second, the vector is modified by recombineering to include a positive selection gene neo, from a variety of modular reagents. Finally, through a simple in vitro Gateway recombination, the modified genomic fragment is switched into a vector that contains negative selection cassettes, as well as unique sites for linearization. To demonstrate the usefulness of this protocol, we report targeted disruptions of members of the cadherin gene family, focusing on those that have not been previously studied at the molecular genetic level. This protocol needs 2 weeks to construct a targeting vector, and several vectors can be easily handled simultaneously using common laboratory setup.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Protéine LIF de souris recombinante ESGRO®, ESGRO Leukemia Inhibitory Factor (LIF) supplement for mouse ES cell culture. Each vial contains 10^7 units/ml.
Roche
Chlorhydrate de Trizma®, >99% (titration), pH 7.0-9.0, suitable for FISH
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, pH 5.2, ≥96%
Sigma-Aldrich
Spermidine trihydrochloride, ≥98% (TLC)